The adverse impact of COVID-19 pandemic on cardiovascular disease prevention and management in England, Scotland and Wales: A population-scale analysis of trends in medication data (2022)
Attributed to:
Phase 1 COVID-19 Data and Connectivity – National Core Study (Phase 1 D&C-NCS)
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2021.12.31.21268587
Publication URI: http://dx.doi.org/10.1101/2021.12.31.21268587
Type: Preprint